Genetic testing to guide radiation for advanced cancer
Part of Cancer clinical trials.
This trial tests whether using advanced genetic testing (called OncoTreat and OncoTarget) can help guide radiation treatment for people whose cancer has spread. The goal is to see if tailoring treatment to your cancer's unique genetics makes radiation more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- Your cancer must have spread to other parts of the body (metastatic)
- All visible cancer must be treatable with radiation therapy
- You must be a patient at Good Samaritan University Hospital
- Your blood counts, kidney, and liver function need to be within safe limits
- You cannot be pregnant or breastfeeding, and must be expected to live at least 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This study looks at whether using a detailed genetic test of your tumor can help pick the best first or second treatment for advanced lung, colon, breast, or bladder cancer. The goal is to see if this personalized approach helps people live longer.
This study uses genetic testing of your tumor to find specific mutations and match you with targeted therapies, aiming to improve outcomes for advanced cancers with poor prognosis. If you have pancreatic, liver, or triple negative breast cancer and are starting treatment, this trial may help you access personalized treatment options.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
Hear when a new Personalized Medicine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.